Market Overview

Oppenheimer Reiterates Outperform on Mindray Medical International

Share:

Oppenheimer reiterated its Outperform rating on Mindray Medical International (NYSE: MR). At the moment, Oppenheimer has a price target of $32 placed on the company's stock. On Friday, Mindray added 4.35% to its value to finish the day at $29.27.

 

Related Articles (MR)

View Comments and Join the Discussion!

Posted-In: Mindray Medical OppenheimerReiteration Analyst Ratings

Latest Ratings

StockFirmActionPT
DEWilliam BlairUpgrades
SIXGoldman SachsInitiates Coverage On
HPQCFRAMaintains17.0
DLTRCFRAMaintains110.0
DGCFRAMaintains230.0
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com